IDEAYA Biosciences, Inc.
Total Trades
31
Buys
1
Sells
19
Largest Trade
$1M+
Insiders
6
Institutional Funds
196
Inst. Value
$1M+
Activist Filings
42
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Stein Jeffrey | Director | BUY | $1M+ | 50K | $32.96 | Mar 3, 2026 |
| WHITE MICHAEL ANTHONY | Chief Scientific O… | SELL | $1M+ | 29K | $36.24 | May 31, 2024 |
| WHITE MICHAEL ANTHONY | Chief Scientific O… | EXERCISE | $100K–$500K | 29K | $12.86 | May 31, 2024 |
| Ruiz Briseno Andres | See Remarks | SELL | $50K–$100K | 2K | $46.02 | Feb 13, 2024 |
| Hata Yujiro S | President and CEO | EXERCISE | $100K–$500K | 99K | $4.31 | Feb 12, 2024 |
| Hata Yujiro S | President and CEO | SELL | $1M+ | 99K | $45.24 | Feb 12, 2024 |
| Hata Yujiro S | President and CEO | SELL | $15K–$50K | 628 | $45.00 | Feb 5, 2024 |
| Hata Yujiro S | President and CEO | EXERCISE | $1K–$15K | 628 | $4.31 | Feb 5, 2024 |
| Ruiz Briseno Andres | See Remarks | SELL | $50K–$100K | 2K | $42.03 | Jan 25, 2024 |
| Ruiz Briseno Andres | See Remarks | SELL | $50K–$100K | 2K | $38.01 | Jan 17, 2024 |
| Hata Yujiro S | President and CEO | SELL | $1M+ | 75K | $40.15 | Jan 17, 2024 |
| Hata Yujiro S | President and CEO | EXERCISE | $100K–$500K | 75K | $4.31 | Jan 17, 2024 |
| Throne Jason | Chief Legal Officer | EXERCISE | $50K–$100K | 5K | $12.86 | Nov 7, 2023 |
| Throne Jason | Chief Legal Officer | SELL | $100K–$500K | 5K | $30.09 | Nov 7, 2023 |
| Throne Jason | Chief Legal Officer | EXERCISE | $1K–$15K | 1K | $12.86 | Sep 14, 2023 |
| Throne Jason | Chief Legal Officer | SELL | $15K–$50K | 1K | $30.00 | Sep 14, 2023 |
| Throne Jason | Chief Legal Officer | SELL | $100K–$500K | 4K | $30.03 | Sep 6, 2023 |
| Throne Jason | Chief Legal Officer | EXERCISE | $15K–$50K | 4K | $12.86 | Sep 6, 2023 |
| Ruiz Briseno Andres | See Remarks | SELL | $50K–$100K | 2K | $30.01 | Sep 6, 2023 |
| Stone Paul A. | CFO | SELL | $100K–$500K | 5K | $28.87 | Aug 31, 2023 |
| Stone Paul A. | CFO | SELL | $15K–$50K | 978 | $26.40 | Aug 23, 2023 |
| Stone Paul A. | CFO | SELL | $100K–$500K | 4K | $26.38 | Aug 18, 2023 |
| Throne Jason | Chief Legal Officer | SELL | $100K–$500K | 5K | $25.09 | Aug 11, 2023 |
| Throne Jason | Chief Legal Officer | EXERCISE | $50K–$100K | 5K | $13.34 | Aug 11, 2023 |
| Stone Paul A. | CFO | SELL | $50K–$100K | 3K | $25.05 | Aug 11, 2023 |
| Throne Jason | Chief Legal Officer | SELL | $100K–$500K | 9K | $23.00 | Jul 12, 2023 |
| Throne Jason | Chief Legal Officer | EXERCISE | $50K–$100K | 9K | $10.09 | Jul 12, 2023 |
| Throne Jason | Chief Legal Officer | SELL | $50K–$100K | 4K | $23.02 | Jun 2, 2023 |
| Throne Jason | Chief Legal Officer | EXERCISE | $15K–$50K | 4K | $7.01 | Jun 2, 2023 |
| Throne Jason | Chief Legal Officer | SELL | $1K–$15K | 500 | $23.00 | May 24, 2023 |
| Throne Jason | Chief Legal Officer | EXERCISE | $1K–$15K | 500 | $7.01 | May 24, 2023 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 196 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| Capital Research Global Investors | 5.3M | $1M+ | SH |
| STATE STREET CORP | 4.1M | $1M+ | SH |
| FEDERATED HERMES, INC. | 3.4M | $1M+ | SH |
| Logos Global Management LP | 3.1M | $1M+ | SH |
| Point72 Asset Management, L.P. | 1.8M | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 1.8M | $1M+ | SH |
| Fiera Capital Corp | 1.6M | $1M+ | SH |
| GSK plc | 1.3M | $1M+ | SH |
| Candriam S.C.A. | 1.0M | $1M+ | SH |
| Ensign Peak Advisors, Inc | 979K | $1M+ | SH |
| Fisher Asset Management, LLC | 890K | $1M+ | SH |
| Sofinnova Investments, Inc. | 885K | $1M+ | SH |
| DIMENSIONAL FUND ADVISORS LP | 872K | $1M+ | SH |
| Redmile Group, LLC | 742K | $1M+ | SH |
| Pictet Asset Management Holding SA | 734K | $1M+ | SH |
| First Turn Management, LLC | 724K | $1M+ | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 715K | $1M+ | SH |
| BALYASNY ASSET MANAGEMENT L.P. | 596K | $1M+ | SH |
| Aberdeen Group plc | 561K | $1M+ | SH |
| VANGUARD GROUP INC | 553K | $1M+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
Point72 Asset Management, L.P.
SC 13G/A · Feb 17, 2026
2.1%
1.8M shares
Capital Research Global Investors
SC 13G/A · Feb 12, 2026
6.0%
5.3M shares
SC 13G/A · Jan 8, 2026
3.9%
3.4M shares
SC 13G/A · Nov 14, 2025
7.3%
6.4M shares
SC 13G/A · Aug 14, 2025
6.9%
6.2M shares
Capital Research Global Investors
SC 13G · Aug 13, 2025
7.5%
6.6M shares
Point72 Asset Management, L.P.
SC 13G · Jun 9, 2025
5.0%
4.4M shares
SC 13G/A · May 14, 2025
7.3%
6.4M shares
SC 13G/A · Apr 17, 2025
8.1%
7.1M shares
SC 13G/A · Feb 14, 2025
6.8%
5.9M shares
SC 13G/A · Feb 5, 2025
9.7%
8.4M shares
Biotechnology Value Fund, L.P.
SC 13G/A · Nov 14, 2024
1.0%
744K shares
Janus Henderson Group plc EIN #00-0000000
SC 13G/A · Nov 14, 2024
6.1%
5.2M shares
T. ROWE PRICE ASSOCIATES, INC. 52-0556948
SC 13G/A · Nov 14, 2024
4.8%
4.0M shares
SC 13G/A · Nov 12, 2024
15.0%
12.6M shares
Janus Henderson Group plc EIN #00-0000000
SC 13G · Feb 14, 2024
5.5%
3.6M shares
T. ROWE PRICE ASSOCIATES, INC. 52-0556948
SC 13G · Feb 14, 2024
5.5%
3.6M shares
Biotechnology Value Fund, L.P.
SC 13G/A · Feb 14, 2024
2.8%
1.8M shares
Avidity Partners Management LP
SC 13G/A · Feb 14, 2024
2.4%
1.5M shares
SC 13G/A · Feb 14, 2024
2.8%
1.8M shares
The Vanguard Group - 23-1945930
SC 13G · Feb 13, 2024
5.4%
3.5M shares
SC 13G · Feb 12, 2024
11.1%
8.2M shares
SC 13G/A · Feb 1, 2024
2.4%
1.6M shares
SC 13G/A · Jan 25, 2024
8.4%
5.4M shares
SC 13G/A · Jan 18, 2024
6.0%
3.9M shares
Biotechnology Value Fund, L.P.
SC 13G · Mar 24, 2023
2.7%
1.3M shares
SC 13G · Feb 27, 2023
5.4%
2.6M shares
SC 13G/A · Feb 14, 2023
8.1%
3.9M shares
Avidity Partners Management LP
SC 13G/A · Feb 14, 2023
7.9%
3.8M shares
SC 13G/A · Feb 14, 2023
4.6%
2.2M shares
T. ROWE PRICE ASSOCIATES, INC. 52-0556948
SC 13G/A · Feb 14, 2023
3.5%
1.7M shares
Biotechnology Value Fund, L.P.
SC 13G/A · Feb 14, 2023
2.4%
1.2M shares
SC 13G/A · Feb 14, 2023
0.0%
0 shares
SC 13G/A · Feb 1, 2023
6.0%
2.9M shares
SC 13G/A · Jan 31, 2023
7.4%
3.5M shares
SC 13G · Oct 27, 2022
5.2%
2.5M shares
Biotechnology Value Fund, L.P.
SC 13G · May 2, 2022
2.8%
1.1M shares
T. ROWE PRICE ASSOCIATES, INC. 52-0556948
SC 13G · Feb 14, 2022
7.0%
2.7M shares
(entities only Federated Hermes, Inc.
SC 13G · Feb 14, 2022
6.0%
2.3M shares
Avidity Partners Management LP
SC 13G/A · Feb 14, 2022
6.6%
2.6M shares
SC 13G/A · Feb 14, 2022
6.5%
2.5M shares
Biotechnology Value Fund, L.P.
SC 13G/A · Feb 12, 2022
1.0%
299 shares